The DATA Extension Study: 2 Years of Combined Denosumab and Teriparatide in Postmenopausal Women with Osteoporosis: A Randomized Controlled Trial

被引：0
|
作者：
Leder, Benjamin [1 ]
Uihlein, Alexander [2 ]
Tsai, Joy [3 ]
Neer, Robert [3 ]
Siwila-Sackman, Erica [3 ]
Zhu, Yuli [3 ]
Foley, Katelyn [3 ]
Lee, Hang [3 ]
Burnett-Bowie, Sherri-Ann [3 ]
机构：
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cambridge, MA 02138 USA
[2] Northwestern Mem Fac Fdn, Chicago, IL USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1019
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in postmenopausal women with osteoporosis: TERABIT study
    Chiba, Ko
    Okazaki, Narihiro
    Osaki, Makoto
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 150 - 150
  • [12] Rapid and Large BMD Increases in Postmenopausal Women Treated With Combined High-Dose Teriparatide and Denosumab: The DATA-HD Randomized Controlled Trial
    Leder, Benjamin
    Lee, Hang
    David, Natalie
    Eastell, Richard
    Joy, Tsai
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 25 - 25
  • [13] TEN YEARS OF DENOSUMAB (DMAB) TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM EXTENSION TRIAL
    Bone, H. G.
    Brandi, M. L.
    Brown, J. P.
    Chapurlat, R.
    Cummings, S. R.
    Czerwinski, E.
    Fahrleitner-Pammer, A.
    Kendler, D. L.
    Lippuner, K.
    Reginster, J. -Y.
    Vittinghoff, E.
    Daizadeh, N. S.
    Wang, A.
    Dakin, P.
    Wagman, R. B.
    Papapoulos, S. E.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S135 - S136
  • [14] Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial
    Tsai, Joy N.
    Lee, Hang
    David, Natalie L.
    Eastell, Richard
    Leder, Benjamin Z.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (10): : 767 - 775
  • [15] 6 YEARS' DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: FIRST 3 YEARS OF THE FREEDOM EXTENSION
    Papapoulos, S.
    Brown, J. P.
    Bone, H. G.
    Chapurlat, R.
    Franchimont, N.
    Brandi, M. L.
    Czerwinski, E.
    Krieg, M. A.
    Man, Z.
    Mellstrom, D.
    Radominski, S. C.
    Reginster, J. Y.
    Resch, H.
    Roman Ivorra, J. A.
    Roux, C.
    Daizadeh, N. S.
    Geller, M. L.
    Smith, S.
    Wagman, R. B.
    Cummings, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S476 - S477
  • [16] Denosumab treatment for 6 years in postmenopausal women with osteoporosis: The first 3 years of the freedom extension
    Mellstrom, D.
    Brown, J.
    Bone, H.
    Chapurlat, R.
    Franchimont, N.
    Brandi, M.
    Czerwinski, E.
    Krieg, M. -A.
    Man, Z.
    Radominski, S.
    Resch, H.
    Roman, J.
    Roux, C.
    Daizadeh, N.
    Geller, M.
    Smith, S.
    Wagman, R.
    Cummings, S.
    Papapoulos, S.
    BONE, 2012, 50 : S53 - S54
  • [17] FIVE YEARS OF DENOSUMAB TREATMENT IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: PRELIMINARY RESULTS FROM THE FREEDOM EXTENSION STUDY
    Papapoulos, S.
    Chapurlat, R.
    Brandi, M.
    Brown, J.
    Czerwinski, E.
    Daizadeh, N.
    Grauer, A.
    Krieg, M.
    Man, Z.
    Mellstrom, D.
    Radominski, S.
    Reginster, J.
    Resch, H.
    Roman, J.
    Roux, C.
    Cummings, S.
    Libanati, C.
    Bone, H.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 26 - 26
  • [18] COMPARING CLINICAL AND ECONOMIC OUTCOMES OF DENOSUMAB AND TERIPARATIDE MEDICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 10 YEARS EXPERIENCE
    Zidan, S. F. Z.
    Elsalmawy, A. H. E.
    Bajuifer, S. J. B.
    Almaimani, W. H. A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S108 - S109
  • [19] Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
    Koh, Jung-Min
    Chung, Dong Jin
    Chung, Yoon-Sok
    Kang, Moo-Il
    Kim, In-Ju
    Min, Yong-Ki
    Oh, Han-Jin
    Park, Il Hyung
    Lee, Yil-Seob
    Kravitz, Barbara
    Waterhouse, Brian
    Nino, Antonio
    Fitzpatrick, Lorraine A.
    YONSEI MEDICAL JOURNAL, 2016, 57 (04) : 905 - 914
  • [20] Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: A randomized, controlled trial
    Anastasilakis, A. D.
    Goulis, D. G.
    Polyzos, S. A.
    Gerou, S.
    Koukoulis, G.
    Kita, M.
    Avramidis, A.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (04) : 281 - 285
12345